31 results
8-K
EX-2.1
SPRY
ARS Pharmaceuticals Inc
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm
Bribery Act of 2010 or any other anti-bribery or anti-corruption Law (collectively, the “Anti-Bribery Laws”). Neither the Company nor any of its
8-K
EX-10.5
g75lsp
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm
8-K
EX-10.3
hf8cmd3vrhv1oa1 0mhg
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm
8-K
EX-10.4
3vepmyo3
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm
8-K
ut8u6e2 4s
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm
DEFM14A
e93 zok2d444
6 Oct 22
Proxy related to merger
4:16pm
PRER14A
8erxjc9
16 Sep 22
Preliminary revised proxy
4:56pm
PREM14A
durm1cqk 3mjnh
11 Aug 22
Preliminary proxy related to merger
5:22pm
DEFA14A
6hvi 8lfvnonmu
21 Jul 22
Additional proxy soliciting materials
5:05pm
8-K
EX-2.1
3jbi 9c1z172mm3m8
21 Jul 22
Silverback Therapeutics and ARS Pharmaceuticals Announce Merger
5:01pm